Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kuiken

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Blood|May 29, 2026
DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell LymphomaCamiel Göbel, Rachele Niccolai, Sebastian Gregoricchio, et al.
Neoplasia (New York, N.Y.)|October 28, 2025
Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibitionRachele Niccolai, Camiel Göbel, Klevis Ndoj, et al.
Oncogene|October 27, 2021
Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contextsHendrik J Kuiken, Sabin Dhakal, Laura M Selfors, et al.
Cell Reports. Medicine|March 20, 2024
Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapseMengnuo Chen, Sara Mainardi, Cor Lieftink, et al.
Nature Communications|November 17, 2020
Transient commensal clonal interactions can drive tumor metastasisSuha Naffar-Abu Amara, Hendrik J Kuiken, Laura M Selfors, et al.
Cancer Discovery|March 27, 2024
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment StrategyMatheus Henrique Dias, Anoek Friskes, Siying Wang, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Blood|May 29, 2026
DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell LymphomaCamiel Göbel, Rachele Niccolai, Sebastian Gregoricchio, et al.
Neoplasia (New York, N.Y.)|October 28, 2025
Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibitionRachele Niccolai, Camiel Göbel, Klevis Ndoj, et al.
Oncogene|October 27, 2021
Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contextsHendrik J Kuiken, Sabin Dhakal, Laura M Selfors, et al.
Cell Reports. Medicine|March 20, 2024
Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapseMengnuo Chen, Sara Mainardi, Cor Lieftink, et al.
Nature Communications|November 17, 2020
Transient commensal clonal interactions can drive tumor metastasisSuha Naffar-Abu Amara, Hendrik J Kuiken, Laura M Selfors, et al.
Cancer Discovery|March 27, 2024
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment StrategyMatheus Henrique Dias, Anoek Friskes, Siying Wang, et al.
Pageof 3